Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kota

Showing results (51-60 of 8,882) with videos related to

Pageof 889
Sort By:
Journal of Epidemiology|March 20, 2018
Japanese Legacy Cohorts: A New Series of Special Articles Has StartedKota Katanoda
Nihon Jinzo Gakkai Shi|December 17, 2008
[ABO-incompatible kidney transplantation: update]Kota Takahashi
Neuroreport|December 23, 2023
Contingency learning on the proportional congruency effect of the Stroop task is manifest in deviant processingKota Suzuki
Experimental Brain Research|July 4, 2024
Rare incompatible stimuli evoke visual mismatch negativity in a flanker taskKota Suzuki
Nature Reviews. Drug Discovery|June 12, 2026
Upcoming FDA approval decisions in Q3 2026Swetha Kota
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 4, 2026
[How Can We Overcome the Gap in Social Implementation of Medical Technology (Drug & Digital Device Loss) between Japan and Overseas?]Kota Kodama
Brain and Nerve = Shinkei Kenkyu No Shinpo|January 15, 2016
[Treatment for Patients with Charcot-Marie-Tooth Disease: Orthopaedic Aspects]Kota Watanabe
Journal of Epidemiology|April 8, 2016
Neuroblastoma Mass Screening--What Can We Learn From It?Kota Katanoda
Nihon Eiseigaku Zasshi. Japanese Journal of Hygiene|December 21, 2020
[Involvement of Notch1 and ALK4/5 Signaling Pathways in Renal Tubular Cell Death: Their Application to Clarification of Cadmium Toxicity]Kota Fujiki
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|March 1, 2022
[New drug for type 2 diabetes: introduction of oral Semaglutide (Rybelsus<sup>®</sup> tablets), an oral GLP-1 receptor agonist]Kota Miyasaka
Pageof 889

Showing results (51-60 of 8,882) with videos related to

Sort By:
Pageof 889
Journal of Epidemiology|March 20, 2018
Japanese Legacy Cohorts: A New Series of Special Articles Has StartedKota Katanoda
Nihon Jinzo Gakkai Shi|December 17, 2008
[ABO-incompatible kidney transplantation: update]Kota Takahashi
Neuroreport|December 23, 2023
Contingency learning on the proportional congruency effect of the Stroop task is manifest in deviant processingKota Suzuki
Experimental Brain Research|July 4, 2024
Rare incompatible stimuli evoke visual mismatch negativity in a flanker taskKota Suzuki
Nature Reviews. Drug Discovery|June 12, 2026
Upcoming FDA approval decisions in Q3 2026Swetha Kota
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 4, 2026
[How Can We Overcome the Gap in Social Implementation of Medical Technology (Drug & Digital Device Loss) between Japan and Overseas?]Kota Kodama
Brain and Nerve = Shinkei Kenkyu No Shinpo|January 15, 2016
[Treatment for Patients with Charcot-Marie-Tooth Disease: Orthopaedic Aspects]Kota Watanabe
Journal of Epidemiology|April 8, 2016
Neuroblastoma Mass Screening--What Can We Learn From It?Kota Katanoda
Nihon Eiseigaku Zasshi. Japanese Journal of Hygiene|December 21, 2020
[Involvement of Notch1 and ALK4/5 Signaling Pathways in Renal Tubular Cell Death: Their Application to Clarification of Cadmium Toxicity]Kota Fujiki
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|March 1, 2022
[New drug for type 2 diabetes: introduction of oral Semaglutide (Rybelsus<sup>®</sup> tablets), an oral GLP-1 receptor agonist]Kota Miyasaka
Pageof 889